{
"info": {
"nct_id": "NCT00331760",
"official_title": "A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) to the Pelvis ± Chemotherapy for Post-Operative Patients With Either Endometrial or Cervical Carcinoma",
"inclusion_criteria": "Healthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "DISEASE CHARACTERISTICS:\n\n* Must have undergone a hysterectomy (total abdominal, vaginal, radical, or laparoscopic-assisted vaginal) within 7 weeks prior to study entry\n\n * Patients with endometrial cancer must have also undergone a bilateral salpingo-oophorectomy\n* Histologically confirmed diagnosis of 1 of the following:\n\n * Endometrial cancer meeting 1 of the following criteria:\n\n * Stage IB grade 3, IC grade 1-3, IIA, or IIB disease requiring postoperative pelvic radiotherapy\n * Unstaged (no lymph node dissection or sampling) stage IB grade 2 disease\n * Stage IIIC with all of the following:\n\n * Pelvic lymph node positive only\n * Para-aortic nodes sampled negative\n * Not receiving chemotherapy\n * Cervical cancer meeting 1 of the following criteria:\n\n * Post-radical hysterectomy and requires postoperative pelvic radiotherapy due to any of the following:\n\n * Positive pelvic nodes (negative para-aortic nodes)\n * Microscopic parametrial involvement and negative margins\n * Disease qualified by Sedlis criteria must have 2 of the following risk factors:\n\n * 1/3 or more stromal invasion\n * Lymph-vascular space invasion\n * Large clinical tumor diameter (≥ 4 cm)\n * Post-simple hysterectomy with negative margins and negative nodes by CT scan, MRI, or positron emission tomography-CT scan\n* No requirement for extended-field radiotherapy beyond the pelvis\n* No histologically confirmed papillary serous, clear cell, or neuroendocrine (either large or small cell) disease, endometrial stromal sarcoma, leiomyosarcoma, or malignant müllerian mixed tumor\n* No evidence of metastatic disease outside of the pelvis\n* No microscopic involvement of the resection margin (< 3 mm)\n\nPATIENT CHARACTERISTICS:\n\n* Zubrod performance status 0-2\n* WBC (white blood cell count) ≥ 4,000/mm³ (cervical cancer patients only)\n* Absolute neutrophil count ≥ 1,800/mm³ (cervical cancer patients only)\n* Platelet count ≥ 100,000/mm³ (cervical cancer patients only)\n* Hemoglobin ≥ 8.0 g/dL (transfusion allowed)\n* Serum creatinine ≤ 2.0 mg/dL (cervical cancer patients only)\n* Creatinine clearance ≥ 50 mL/min (cervical cancer patients only)\n* AST (aspartate aminotransferase) ≤ 2 times upper limit of normal\n* Bilirubin ≤ 2 times upper limit of normal\n* Patients must not exceed the weight and size limits of the treatment table or CT scanner\n\n * No mental status changes or bladder control problems that would preclude study compliance with bladder-filling instructions\n* No active inflammatory bowel disease\n* No severe, active, concurrent illness, defined as any of the following:\n\n * Unstable angina and/or congestive heart failure requiring hospitalization within the past 6 months\n * Transmural myocardial infarction within the past 6 months\n * Acute bacterial or fungal infection requiring IV antibiotics\n * Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy\n * Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects\n * AIDS\n* No history of allergy to cisplatin (cervical cancer patients)\n* No prior invasive malignancy (except nonmelanoma skin cancer) unless disease-free for ≥ 3 years\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics\n* No prior radiotherapy to the pelvis that would result in overlap of radiotherapy fields\n* No prior platinum-based chemotherapy (cervical cancer patients)\n* No concurrent prophylactic growth factors (e.g., filgrastim [G-CSF], sargramostim [GM-CSF], or pegfilgrastim)\n* No concurrent prophylactic thrombopoietic agents\n* No concurrent amifostine or other protective agents"
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "DISEASE CHARACTERISTICS:",
"criterions": [
{
"exact_snippets": "DISEASE CHARACTERISTICS",
"criterion": "disease characteristics",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "N/A"
}
]
}
]
},
{
"line": "* Must have undergone a hysterectomy (total abdominal, vaginal, radical, or laparoscopic-assisted vaginal) within 7 weeks prior to study entry",
"criterions": [
{
"exact_snippets": "Must have undergone a hysterectomy (total abdominal, vaginal, radical, or laparoscopic-assisted vaginal)",
"criterion": "hysterectomy",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"total abdominal",
"vaginal",
"radical",
"laparoscopic-assisted vaginal"
]
}
]
},
{
"exact_snippets": "within 7 weeks prior to study entry",
"criterion": "time since hysterectomy",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 7,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Patients with endometrial cancer must have also undergone a bilateral salpingo-oophorectomy",
"criterions": [
{
"exact_snippets": "Patients with endometrial cancer",
"criterion": "endometrial cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "must have also undergone a bilateral salpingo-oophorectomy",
"criterion": "bilateral salpingo-oophorectomy",
"requirements": [
{
"requirement_type": "procedure",
"expected_value": "completed"
}
]
}
]
},
{
"line": "* Histologically confirmed diagnosis of 1 of the following:",
"criterions": [
{
"exact_snippets": "Histologically confirmed diagnosis",
"criterion": "diagnosis confirmation",
"requirements": [
{
"requirement_type": "method",
"expected_value": "histologically"
}
]
}
]
},
{
"line": "* Endometrial cancer meeting 1 of the following criteria:",
"criterions": [
{
"exact_snippets": "Endometrial cancer",
"criterion": "endometrial cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Stage IB grade 3, IC grade 1-3, IIA, or IIB disease requiring postoperative pelvic radiotherapy",
"criterions": [
{
"exact_snippets": "Stage IB grade 3",
"criterion": "disease stage and grade",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IB"
},
{
"requirement_type": "grade",
"expected_value": {
"operator": "=",
"value": 3,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "IC grade 1-3",
"criterion": "disease stage and grade",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IC"
},
{
"requirement_type": "grade",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1,
"unit": "N/A"
},
{
"operator": "<=",
"value": 3,
"unit": "N/A"
}
]
}
}
]
},
{
"exact_snippets": "IIA",
"criterion": "disease stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IIA"
}
]
},
{
"exact_snippets": "IIB",
"criterion": "disease stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IIB"
}
]
},
{
"exact_snippets": "requiring postoperative pelvic radiotherapy",
"criterion": "postoperative pelvic radiotherapy",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "* Unstaged (no lymph node dissection or sampling) stage IB grade 2 disease",
"criterions": [
{
"exact_snippets": "Unstaged (no lymph node dissection or sampling)",
"criterion": "lymph node dissection or sampling",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "stage IB",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "IB"
}
]
},
{
"exact_snippets": "grade 2 disease",
"criterion": "cancer grade",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "2"
}
]
}
]
},
{
"line": "* Stage IIIC with all of the following:",
"criterions": [
{
"exact_snippets": "Stage IIIC",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IIIC"
}
]
}
]
},
{
"line": "* Pelvic lymph node positive only",
"criterions": [
{
"exact_snippets": "Pelvic lymph node positive",
"criterion": "pelvic lymph node",
"requirements": [
{
"requirement_type": "status",
"expected_value": "positive"
}
]
}
]
},
{
"line": "* Para-aortic nodes sampled negative",
"criterions": [
{
"exact_snippets": "Para-aortic nodes sampled negative",
"criterion": "para-aortic nodes",
"requirements": [
{
"requirement_type": "sampled",
"expected_value": true
},
{
"requirement_type": "result",
"expected_value": "negative"
}
]
}
]
},
{
"line": "* Not receiving chemotherapy",
"criterions": [
{
"exact_snippets": "Not receiving chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "receiving",
"expected_value": false
}
]
}
]
},
{
"line": "* Cervical cancer meeting 1 of the following criteria:",
"criterions": [
{
"exact_snippets": "Cervical cancer",
"criterion": "cervical cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Post-radical hysterectomy and requires postoperative pelvic radiotherapy due to any of the following:",
"criterions": [
{
"exact_snippets": "Post-radical hysterectomy",
"criterion": "radical hysterectomy",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
},
{
"exact_snippets": "requires postoperative pelvic radiotherapy",
"criterion": "postoperative pelvic radiotherapy",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "* Positive pelvic nodes (negative para-aortic nodes)",
"criterions": [
{
"exact_snippets": "Positive pelvic nodes",
"criterion": "pelvic nodes",
"requirements": [
{
"requirement_type": "status",
"expected_value": "positive"
}
]
},
{
"exact_snippets": "negative para-aortic nodes",
"criterion": "para-aortic nodes",
"requirements": [
{
"requirement_type": "status",
"expected_value": "negative"
}
]
}
]
},
{
"line": "* Microscopic parametrial involvement and negative margins",
"criterions": [
{
"exact_snippets": "Microscopic parametrial involvement",
"criterion": "parametrial involvement",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
},
{
"requirement_type": "extent",
"expected_value": "microscopic"
}
]
},
{
"exact_snippets": "negative margins",
"criterion": "margins",
"requirements": [
{
"requirement_type": "status",
"expected_value": "negative"
}
]
}
]
},
{
"line": "* Disease qualified by Sedlis criteria must have 2 of the following risk factors:",
"criterions": [
{
"exact_snippets": "Disease qualified by Sedlis criteria",
"criterion": "disease qualification",
"requirements": [
{
"requirement_type": "qualification",
"expected_value": "Sedlis criteria"
}
]
},
{
"exact_snippets": "must have 2 of the following risk factors",
"criterion": "risk factors",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "risk factors"
}
}
]
}
]
},
{
"line": "* 1/3 or more stromal invasion",
"criterions": [
{
"exact_snippets": "1/3 or more stromal invasion",
"criterion": "stromal invasion",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "third"
}
}
]
}
]
},
{
"line": "* Lymph-vascular space invasion",
"criterions": [
{
"exact_snippets": "Lymph-vascular space invasion",
"criterion": "lymph-vascular space invasion",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Large clinical tumor diameter (≥ 4 cm)",
"criterions": [
{
"exact_snippets": "Large clinical tumor diameter (≥ 4 cm)",
"criterion": "clinical tumor diameter",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "cm"
}
}
]
}
]
},
{
"line": "* Post-simple hysterectomy with negative margins and negative nodes by CT scan, MRI, or positron emission tomography-CT scan",
"criterions": [
{
"exact_snippets": "Post-simple hysterectomy",
"criterion": "hysterectomy",
"requirements": [
{
"requirement_type": "type",
"expected_value": "simple"
},
{
"requirement_type": "post-surgery status",
"expected_value": true
}
]
},
{
"exact_snippets": "negative margins",
"criterion": "margins",
"requirements": [
{
"requirement_type": "status",
"expected_value": "negative"
}
]
},
{
"exact_snippets": "negative nodes by CT scan, MRI, or positron emission tomography-CT scan",
"criterion": "nodes",
"requirements": [
{
"requirement_type": "status",
"expected_value": "negative"
},
{
"requirement_type": "detection method",
"expected_value": [
"CT scan",
"MRI",
"positron emission tomography-CT scan"
]
}
]
}
]
},
{
"line": "* No requirement for extended-field radiotherapy beyond the pelvis",
"criterions": [
{
"exact_snippets": "No requirement for extended-field radiotherapy beyond the pelvis",
"criterion": "extended-field radiotherapy",
"requirements": [
{
"requirement_type": "location",
"expected_value": "pelvis"
}
]
}
]
},
{
"line": "* No histologically confirmed papillary serous, clear cell, or neuroendocrine (either large or small cell) disease, endometrial stromal sarcoma, leiomyosarcoma, or malignant müllerian mixed tumor",
"criterions": [
{
"exact_snippets": "No histologically confirmed papillary serous",
"criterion": "papillary serous disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No histologically confirmed ... clear cell",
"criterion": "clear cell disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No histologically confirmed ... neuroendocrine (either large or small cell)",
"criterion": "neuroendocrine disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No histologically confirmed ... endometrial stromal sarcoma",
"criterion": "endometrial stromal sarcoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No histologically confirmed ... leiomyosarcoma",
"criterion": "leiomyosarcoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No histologically confirmed ... malignant müllerian mixed tumor",
"criterion": "malignant müllerian mixed tumor",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No evidence of metastatic disease outside of the pelvis",
"criterions": [
{
"exact_snippets": "No evidence of metastatic disease outside of the pelvis",
"criterion": "metastatic disease",
"requirements": [
{
"requirement_type": "location",
"expected_value": "pelvis"
}
]
}
]
},
{
"line": "* No microscopic involvement of the resection margin (< 3 mm)",
"criterions": [
{
"exact_snippets": "No microscopic involvement of the resection margin (< 3 mm)",
"criterion": "microscopic involvement of the resection margin",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
},
{
"requirement_type": "distance",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "mm"
}
}
]
}
]
},
{
"line": "* Zubrod performance status 0-2",
"criterions": [
{
"exact_snippets": "Zubrod performance status 0-2",
"criterion": "Zubrod performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* WBC (white blood cell count) ≥ 4,000/mm³ (cervical cancer patients only)",
"criterions": [
{
"exact_snippets": "WBC (white blood cell count) ≥ 4,000/mm³",
"criterion": "white blood cell count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 4000,
"unit": "mm³"
}
}
]
}
]
},
{
"line": "* Absolute neutrophil count ≥ 1,800/mm³ (cervical cancer patients only)",
"criterions": [
{
"exact_snippets": "Absolute neutrophil count ≥ 1,800/mm³",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1800,
"unit": "mm³"
}
}
]
},
{
"exact_snippets": "cervical cancer patients only",
"criterion": "cervical cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Platelet count ≥ 100,000/mm³ (cervical cancer patients only)",
"criterions": [
{
"exact_snippets": "Platelet count ≥ 100,000/mm³",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "mm³"
}
}
]
},
{
"exact_snippets": "cervical cancer patients only",
"criterion": "cervical cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Hemoglobin ≥ 8.0 g/dL (transfusion allowed)",
"criterions": [
{
"exact_snippets": "Hemoglobin ≥ 8.0 g/dL",
"criterion": "hemoglobin level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 8.0,
"unit": "g/dL"
}
}
]
},
{
"exact_snippets": "transfusion allowed",
"criterion": "transfusion",
"requirements": [
{
"requirement_type": "allowance",
"expected_value": true
}
]
}
]
},
{
"line": "* Serum creatinine ≤ 2.0 mg/dL (cervical cancer patients only)",
"criterions": [
{
"exact_snippets": "Serum creatinine ≤ 2.0 mg/dL",
"criterion": "serum creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.0,
"unit": "mg/dL"
}
}
]
},
{
"exact_snippets": "cervical cancer patients only",
"criterion": "cervical cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Creatinine clearance ≥ 50 mL/min (cervical cancer patients only)",
"criterions": [
{
"exact_snippets": "Creatinine clearance ≥ 50 mL/min",
"criterion": "creatinine clearance",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "mL/min"
}
}
]
},
{
"exact_snippets": "cervical cancer patients only",
"criterion": "cervical cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* AST (aspartate aminotransferase) ≤ 2 times upper limit of normal",
"criterions": [
{
"exact_snippets": "AST (aspartate aminotransferase) ≤ 2 times upper limit of normal",
"criterion": "AST (aspartate aminotransferase)",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "times upper limit of normal"
}
}
]
}
]
},
{
"line": "* Bilirubin ≤ 2 times upper limit of normal",
"criterions": [
{
"exact_snippets": "Bilirubin ≤ 2 times upper limit of normal",
"criterion": "bilirubin level",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "times upper limit of normal"
}
}
]
}
]
},
{
"line": "* Patients must not exceed the weight and size limits of the treatment table or CT scanner",
"criterions": [
{
"exact_snippets": "weight ... limits of the treatment table or CT scanner",
"criterion": "weight",
"requirements": [
{
"requirement_type": "limit",
"expected_value": "not exceed"
}
]
},
{
"exact_snippets": "size limits of the treatment table or CT scanner",
"criterion": "size",
"requirements": [
{
"requirement_type": "limit",
"expected_value": "not exceed"
}
]
}
]
},
{
"line": "* No mental status changes or bladder control problems that would preclude study compliance with bladder-filling instructions",
"criterions": [
{
"exact_snippets": "No mental status changes",
"criterion": "mental status changes",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No ... bladder control problems",
"criterion": "bladder control problems",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No active inflammatory bowel disease",
"criterions": [
{
"exact_snippets": "No active inflammatory bowel disease",
"criterion": "inflammatory bowel disease",
"requirements": [
{
"requirement_type": "activity",
"expected_value": false
}
]
}
]
},
{
"line": "* No severe, active, concurrent illness, defined as any of the following:",
"criterions": [
{
"exact_snippets": "severe, active, concurrent illness",
"criterion": "concurrent illness",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "not severe"
},
{
"requirement_type": "activity",
"expected_value": "not active"
}
]
}
]
},
{
"line": "* Unstable angina and/or congestive heart failure requiring hospitalization within the past 6 months",
"criterions": [
{
"exact_snippets": "Unstable angina",
"criterion": "unstable angina",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "congestive heart failure requiring hospitalization within the past 6 months",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "hospitalization",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Transmural myocardial infarction within the past 6 months",
"criterions": [
{
"exact_snippets": "Transmural myocardial infarction within the past 6 months",
"criterion": "transmural myocardial infarction",
"requirements": [
{
"requirement_type": "time since event",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Acute bacterial or fungal infection requiring IV antibiotics",
"criterions": [
{
"exact_snippets": "Acute bacterial or fungal infection",
"criterion": "infection type",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"bacterial",
"fungal"
]
},
{
"requirement_type": "severity",
"expected_value": "acute"
}
]
},
{
"exact_snippets": "requiring IV antibiotics",
"criterion": "treatment requirement",
"requirements": [
{
"requirement_type": "treatment",
"expected_value": "IV antibiotics"
}
]
}
]
},
{
"line": "* Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy",
"criterions": [
{
"exact_snippets": "Chronic obstructive pulmonary disease exacerbation",
"criterion": "chronic obstructive pulmonary disease exacerbation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "other respiratory illness requiring hospitalization",
"criterion": "respiratory illness",
"requirements": [
{
"requirement_type": "hospitalization",
"expected_value": true
}
]
},
{
"exact_snippets": "other respiratory illness ... precluding study therapy",
"criterion": "respiratory illness",
"requirements": [
{
"requirement_type": "preclusion of study therapy",
"expected_value": true
}
]
}
]
},
{
"line": "* Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects",
"criterions": [
{
"exact_snippets": "Hepatic insufficiency resulting in clinical jaundice",
"criterion": "hepatic insufficiency",
"requirements": [
{
"requirement_type": "resulting condition",
"expected_value": "clinical jaundice"
}
]
},
{
"exact_snippets": "Hepatic insufficiency resulting in ... coagulation defects",
"criterion": "hepatic insufficiency",
"requirements": [
{
"requirement_type": "resulting condition",
"expected_value": "coagulation defects"
}
]
}
]
},
{
"line": "* AIDS",
"criterions": [
{
"exact_snippets": "AIDS",
"criterion": "AIDS",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* No history of allergy to cisplatin (cervical cancer patients)",
"criterions": [
{
"exact_snippets": "No history of allergy to cisplatin",
"criterion": "allergy to cisplatin",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
}
]
},
{
"line": "* No prior invasive malignancy (except nonmelanoma skin cancer) unless disease-free for ≥ 3 years",
"criterions": [
{
"exact_snippets": "No prior invasive malignancy (except nonmelanoma skin cancer)",
"criterion": "prior invasive malignancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "unless disease-free for ≥ 3 years",
"criterion": "disease-free period",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "years"
}
}
]
}
]
},
{
"line": "PRIOR CONCURRENT THERAPY:",
"criterions": [
{
"exact_snippets": "PRIOR CONCURRENT THERAPY",
"criterion": "prior concurrent therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* See Disease Characteristics",
"criterions": [
{
"exact_snippets": "Disease Characteristics",
"criterion": "disease characteristics",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "See Disease Characteristics"
}
]
}
]
},
{
"line": "* No prior radiotherapy to the pelvis that would result in overlap of radiotherapy fields",
"criterions": [
{
"exact_snippets": "No prior radiotherapy to the pelvis",
"criterion": "prior radiotherapy to the pelvis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "overlap of radiotherapy fields",
"criterion": "overlap of radiotherapy fields",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No prior platinum-based chemotherapy (cervical cancer patients)",
"criterions": [
{
"exact_snippets": "No prior platinum-based chemotherapy (cervical cancer patients)",
"criterion": "prior platinum-based chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No concurrent prophylactic growth factors (e.g., filgrastim [G-CSF], sargramostim [GM-CSF], or pegfilgrastim)",
"criterions": [
{
"exact_snippets": "No concurrent prophylactic growth factors (e.g., filgrastim [G-CSF], sargramostim [GM-CSF], or pegfilgrastim)",
"criterion": "concurrent prophylactic growth factors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No concurrent prophylactic thrombopoietic agents",
"criterions": [
{
"exact_snippets": "No concurrent prophylactic thrombopoietic agents",
"criterion": "concurrent prophylactic thrombopoietic agents",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No concurrent amifostine or other protective agents",
"criterions": [
{
"exact_snippets": "No concurrent amifostine",
"criterion": "amifostine",
"requirements": [
{
"requirement_type": "concurrent use",
"expected_value": false
}
]
},
{
"exact_snippets": "No concurrent ... other protective agents",
"criterion": "other protective agents",
"requirements": [
{
"requirement_type": "concurrent use",
"expected_value": false
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "PATIENT CHARACTERISTICS:",
"criterions": []
}
]
}